Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|March 28, 2024
Characterization of atypical T cells generated during ex vivo expansion process for T cell-based adoptive immunotherapyPatricia Mercier-Letondal, Abhishek Kumar, Chrystel Marton, et al.
Cells|June 28, 2023
Chrysin-Induced Regression of Angiogenesis via an Induction of DNA Damage Response and Oxidative Stress in In Vitro and In Vivo Models of MelanomaAicha Sassi, Maxime Fredon, Alexia K Cotte, et al.
Nature Communications|January 24, 2018
Lysophosphatidylcholine acyltransferase 2-mediated lipid droplet production supports colorectal cancer chemoresistanceAlexia Karen Cotte, Virginie Aires, Maxime Fredon, et al.
Molecular Therapy. Oncology|January 1, 2026
Evaluation of dasatinib and ponatinib for the control of CD123 CAR-T cell functionalitiesCharles-Frédéric Mantion, Sabeha Biichlé, Xavier Roussel, et al.
Iscience|June 22, 2026
Metformin dual-targets metabolism and survival pathways in BPDCNZineb Mekkaoui, Ludivine Dal Zuffo, Mathieu Vetter, et al.
Cancers|July 9, 2022
Umbilical Cord Blood as a Source of Less Differentiated T Cells to Produce CD123 CAR-T CellsBlandine Caël, Jeanne Galaine, Isabelle Bardey, et al.
Ejhaem|August 22, 2025
Venetoclax in the Therapeutic Strategy for BPDCN ManagementMargaux Poussard, Maxime Fredon, Imane Belakri, et al.
Ejhaem|July 18, 2022
BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR-T cell cytotoxicityMargaux Poussard, Laure Philippe, Maxime Fredon, et al.
Haematologica|February 5, 2026
Pivekimab sunirine in blastic plasmacytoid dendritic cell neoplasm: assessing spatial response and unraveling resistance mechanismsMargaux Poussard, Morgane Boichut, Imane Belakri, et al.
Cancer Immunology Research|May 31, 2024
Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T CellsMaxime Fredon, Margaux Poussard, Sabeha Biichlé, et al.
Pageof 2